Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
50.80    -0.20 (-0.39%)
Bid:
49.95
Ask:
50.30
Spread: 0.35 (0.701%)
Market Cap: £670.89m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Trading Update and comment on US Entity List

24 May 2019 07:00



Trading Update and comment on US Entity List

IQE plc

Cardiff, UK. 24th May 2019: IQE plc (AIM: IQE; "IQE", the “Company” or the "Group"), the leading global supplier of advanced wafer products and materials solutions to the semiconductor industry, provides the following trading update in response to action taken by the Bureau of Industry and Security (BIS) of the United States Department of Commerce to add Huawei Technologies Co., Ltd. and 68 of its affiliates (“Huawei”) to the “Entity List” maintained by the Department. The BIS action prohibits the sale to Huawei, by certain of IQE’s customers, of products covered by the Export Administration Regulations (EAR) absent obtaining an appropriate export license.

IQE wishes to clarify its potential exposure to this rapidly evolving situation, as it supplies epitaxial wafers to multiple chip companies in global supply chains, some of whom supply Huawei.

The situation involving the ban is dynamic and it is not clear at this time how long it will remain in force or what the full implications will be. However, IQE believes it is in a strong position to adjust to the possible consequences and scenarios resulting from this in a positive manner. Across all product lines, IQE has supply relationships with multiple non-US customers, so is well placed to adapt to mid to long-term share shifts at both the component (chip) and the OEM level. The majority of IQE’s technologies and supply chains are not affected by the ban and IQE complies fully with the EAR.

In the short-term, IQE believes it may experience some delay to orders and the potential for adjustment of supplier managed inventory levels, predominantly in its Wireless Business Unit. The Photonics and Infrared Business Units are essentially unaffected.

The company has been engaging across its customer base in recent days specifically on this subject and estimates that its current maximum risk exposure to this matter is less than 5% of total FY 2019 revenue guidance.

Although there remains uncertainty and unpredictability related to this specific matter, given the market opportunity IQE faces in H2, the company leaves full year guidance unchanged.

Dr Drew Nelson, Chief Executive of IQE, said:

‘The recent ban on sales of products from US companies to Huawei and its affiliates is a factor completely outside of IQE’s control. However, our long-term strategy of supplying as many of the supply chains into all major OEMs as possible, protects IQEs overall supply to a very significant degree. As a result, we believe the ban will have a limited impact on our mid to long term revenue trajectory. Indeed, the breadth of IQE’s current product range, the new materials technologies being introduced to market over the coming months and years, and IQE’s global manufacturing footprint are powerful mitigating factors in dealing effectively with the ongoing changing geopolitical landscape in our industry."

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

CONTACTS:

  
  
  

IQE plc +44 (0) 29 2083 9400Tim PullenDrew NelsonChris Meadows Canaccord Genuity (Nomad and Joint Broker) + 44 (0) 20 7523 8000Simon BridgesRichard Andrews

Peel Hunt (Joint Broker) +44 (0) 20 7418 8900Edward KnightNick Prowting

ABOUT IQE

http://iqep.com IQE is the leading global supplier of advanced semiconductor wafers that enable a diverse range of applications, supported by an innovative outsourced foundry services portfolio that allows the Group to provide a 'one stop shop' for the wafer needs of the world's leading semiconductor manufacturers. IQE uses advanced crystal growth technology (epitaxy) to manufacture and supply bespoke semiconductor wafers 'epi-wafers' to the major chip manufacturing companies, who then use these wafers to make the chips which form the key components of virtually all high technology systems. IQE is unique in being able to supply wafers using all of the leading crystal growth technology platforms. IQE's products are found in many leading-edge consumer, communication, computing and industrial applications, including a complete range of wafer products for the wireless industry, such as smartphones and wireless infrastructure, Wi-Fi, base stations, and satellite communications; optical communications, optical storage, printing, thermal imagers, leading-edge medical technologies, automotive and aerospace technologies, a variety of advanced silicon based systems and high efficiency concentrator photovoltaic (CPV) solar cells. IQE is headquartered in Cardiff UK and operates multiple manufacturing and R&D facilities worldwide.


Date   Source Headline
9th Sep 202510:24 amBUSForm 8.3 - IQE PLC
9th Sep 20259:56 amRNSForm 8.5 (EPT/RI) - IQE plc
9th Sep 20257:00 amRNSIQE plc: Profit Forecast Directors' Confirmations
8th Sep 20255:17 pmRNSIQE plc: Rule 2.9 Announcement
8th Sep 20253:00 pmRNSIQE plc: Holding(s) in Company
8th Sep 20257:00 amRNSIQE plc: Trading Update & Strategic Review Update
5th Sep 20254:00 pmRNSIQE plc: Holding(s) in Company
1st Sep 20254:00 pmRNSIQE plc: Director/PDMR Shareholding
1st Sep 202510:00 amRNSIQE plc: Total Voting Rights
4th Aug 202511:00 amRNSIQE plc: Total Voting Rights - Amended
1st Aug 20258:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSIQE plc: Director/PDMR Shareholding
30th Jun 20254:00 pmRNSIQE plc: Total Voting Rights and Block Admission
30th Jun 20251:00 pmRNSIQE plc: Result of AGM
30th Jun 20257:00 amRNSIQE plc: AGM Notice
16th Jun 20257:00 amRNS-RIQE plc: Completion of joint ULTRARAM™ project
9th Jun 202512:00 pmRNSIQE plc: Holding(s) in Company
9th Jun 20257:00 amRNSIQE plc: Director/PDMR Shareholding
2nd Jun 20254:00 pmRNSIQE plc: Total Voting Rights
27th May 20257:00 amRNSIQE plc: Notice of AGM and Annual Report
13th May 20257:00 amRNSIQE plc: FY 2024 Financial Results
1st May 20257:00 amRNSIQE plc: Notice of Full Year Results
30th Apr 20254:00 pmRNSIQE plc: Total Voting Rights
10th Apr 20257:00 amRNSIQE plc: IQE and X-FAB sign JDA for GaN Power
4th Apr 202512:00 pmRNSIQE plc: Holding(s) in Company
3rd Apr 20257:00 amRNSIQE plc: Holding(s) in Company
1st Apr 20254:00 pmRNSIQE plc: Total Voting Rights
24th Mar 20257:00 amRNSIQE plc: IQE secures Infrared customer commitments
17th Mar 20251:00 pmRNSIQE plc: Holding(s) in Company
14th Mar 202512:00 pmRNSIQE plc: Director/PDMR Shareholding
14th Mar 20257:00 amRNSIQE plc: Closing of CLN Financing
10th Mar 20254:00 pmRNSIQE plc: Results of General Meeting
28th Feb 20254:00 pmRNSIQE plc: Total Voting Rights
12th Feb 20257:00 amRNSIQE plc: Convertible Loan Note Financing
4th Feb 20257:00 amRNSIQE plc: Total Voting Rights
24th Jan 20257:00 amRNSIQE and Quintessent partner on Quantum Dot for AI
23rd Jan 20257:00 amRNSIQE plc: Pre-close Trading Update
2nd Jan 20254:00 pmRNSIQE plc: Total Voting Rights and Block Admission
20th Dec 20247:00 amRNSIQE plc: Board Change
18th Dec 202410:15 amRNSIQE plc: Holding(s) in Company
12th Dec 20247:00 amRNSIQE plc: Holding(s) in Company
4th Dec 20247:00 amRNSIQE plc: Completion of Pennsylvania site sale
2nd Dec 20244:00 pmRNSIQE plc: Total Voting Rights
29th Nov 202411:24 amRNSLong Term Incentive Plan (LTIP) Award
25th Nov 202410:59 amRNSIQE plc: Holding(s) in Company
18th Nov 20247:00 amRNSIQE plc: Trading Update
15th Nov 20247:00 amRNSHolding(s) in Company
14th Nov 20247:00 amRNSIQE plc: Holding(s) in Company
31st Oct 20247:00 amRNSIQE plc: Total Voting Rights
29th Oct 20247:00 amRNSIQE plc: IQE announces departure of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.